MICB and neoplasm: Having demonstrated that CAR-T cells can specifically target the VLQSQRTD peptide when fused to the TM and intracellular domains of MICB with a rigid linker on transduced cells in cytotoxicity assays, we next focused on harnessing MV as a vector to selectively infect tumor cells and drive transgene expression.